SuperworthApimeds Pharmaceuticals US market cap APUS
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $4.4M
- Highest close in our data
- $21.3M
- May 2026
Apimeds Pharmaceuticals US is worth $4.4M at the close on Oct 23, 2026, at $2.89 a share.
That is up 75% over the last year.
Its highest close in our data was $21.3M in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.4M | $1.5M | $21.3M | +95% |
| 2025 | $2.2M | $1.4M | $4M | n/a |
Against its peers
Companies in Healthcare nearest Apimeds Pharmaceuticals US' size, closest first, today.
| Company | Market cap |
|---|---|
| APUSApimeds Pharmaceuticals US | $4.4M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| BCGBinah Capital | $18.2M |
| VIPVulcan Infrastructure & Power | $19.6M |
| MXCMexco Energy | $20.5M |
| CKXCKX Lands | $21.5M |
| MSGMMotorsport Games | $22.5M |
| ATCHAtlasClear | $24M |
| Peer median | $18.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Apimeds Pharmaceuticals US
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.